FDA
approval
· 2016-09-09
FDA Approved: KRYSTEXXA — Supplemental Application (Horizon Therapeutics USA, Inc.)
Summary
FDA approved a supplemental application for KRYSTEXXA (pegloticase) submitted by Horizon Therapeutics USA, Inc., representing an additional regulatory action on…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KRYSTEXXA (PEGLOTICASE)